Diversified Biotech: Pharmaceutical Companies Fill Gaps in Pipelines

Pharmaceutical companies, having placed their focus on the discovery of effective drugs, the development of such, and creation of technology to advance pharmaceutical production, face a dilemma. It is a difficult process, fraught with challenges, where results are unpredictable; the testing and trial period takes a great length of time, and there are daunting costs, all which are then transferred to the American public. In an effort to increase their production and profits, while minimizing expenses, the pharmaceutical industry is turning to the diversified biotech field as well as the development of biotech drugs.

Biotechnology is a scientific field that relates to biology, and the manipulation of living things as well as bioprocesses, branching out to many areas such as engineering, technology, medicine, and industrial fields that require bioproducts. Starting far back in human history with domestication of plants and animals to advances in agriculture through grafting and hybridization to enhance crops, it is groundbreaking in the present time with the innovations in the production of biotech drugs and the diversified biotech paths available to science. Genetic engineering, cell and tissue culture technologies, biodegradable plastic development, and research into the creation of biofuels name only a few of the new horizons opened by biotechnology. Areas of specialization vary; blue biotechnology focuses on marine and aquatic life processes and developments, green biotechology focuses on the agricultural field, red biotechnology revolves around the medical field, and white biotechnology centers on the industrial field.

As pharmaceutical companies and venture capitalists attempt to thrive, the biotechnology industry provides ample opportunities for investment. Companies are not restricted to the drug research industry alone, although biotechnology certainly will produce advancements in the pharmaceutical field, with new methods of production and sources for drugs that come from the living organisms in the environment. By being so diversified in the implications of the biotechnology field, investors will find their own economic resources building upon new discoveries.

The biofuel field is one of the most promising as an alternative to non-renewable fossil fuels, providing a bargaining chip and bolster for a weak economy. Companies that supplement their finances in the biotechnology industry are not taking a gamble but rather choosing a sensible, stable source that is a well of opportunity. In investing, they will better manage expenses, make the process of drug development more efficient and less costly to the public, and provide the American economy with a well needed boost.

Interested in Big Pharma's diversified biotech portfolios? Looking for information on biotech drugs? Check out our web site.

Article Source: http://EzineArticles.com/?expert=Jeremy_B_Thompson
http://EzineArticles.com/?Diversified-Biotech:-Pharmaceutical-Companies-Fill-Gaps-in-Pipelines&id=6526632

Biotech Startup Funding Growing Rapidly Despite Down Economy

Pharmaceutical companies are able to grab best investment opportunities from biotech field. Little risks are involved in the investments made in biotech startup. For making success in biotech business, we have to identify certain features. We have to develop technology and thus make the market viable. Biotechnology industry organizations provide considerable opportunities in the health care field. Due to the advancement in biotechnology, pharmaceutical companies are making huge investment in this field.

Biotechnology is a branch of science that mainly concerns with the use of bio-processes and living organism in medicine, engineering and technology. There are various branches in biotechnology. Green biotechnology is concerned with agriculture while blue biotechnology deals with aquatic and marine research. Different aspects of industrial field are studied in white biotechnology. Various aspects of medical field like cell and tissue culture technologies, drug development and genetic engineering come under the category of red biotechnology.

Production of new drugs is essential for fighting against various diseases. Preparing medicine products and conducting pharmaceutical researches are the main functions of biotech companies. Biotech startup has to face a lot of challenges while putting various pharmaceutical drugs on the market. For biotech companies, it is very much difficult to find potential venture companies and capitalists for promoting the drugs. Venture capitalists provide funding for the production of drugs. Without this funding, it is very much difficult to continue the production of drugs. Pharmaceutical companies also assist in the marketing of medicines.

Most of the biotech companies are region specific. Biotech companies should be familiar with regional marketplace. Most of the research and development in the pharmaceutical field is quite expensive. Trials and laboratory studies conducted by biotech companies may not provide any assurance or guarantees. Earlier, it takes a lot of years for these researches and laboratory studies. But now many innovations are made in this field for reducing costs of researches. Solid IT infrastructure, competent biotech consulting firm, affordable office space and sources of funding are essential for biotech growth and innovation.

Some of the biotech companies are tied to government or universities subsidized ventures. Such companies are based on a non-profit model. Pharmaceutical companies have to invest on a business model that helps to provide maximum profit. Biotech companies often need the assistance of pharmaceutical companies for the making some crucial discoveries in the field of medicine. New medicines are essential for combating diseases and protecting human beings. Nowadays many venture capitalists are taking interest in biotech companies.

Biotech venture capital needs to be even more careful with investments this year; learn what trends are forcing the industry to be cautious on our web site.

Article Source: http://EzineArticles.com/?expert=Jerry_O_Smith
http://EzineArticles.com/?Biotech-Startup-Funding-Growing-Rapidly-Despite-Down-Economy&id=7119916